Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Black men don’t just have a higher chance of getting prostate cancer; they’re dealing with faster-acting forms way earlier ...

Elevated PSA levels can signal both malignant and benign prostate cancer But what does it mean if the PSA levels rise after a ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations. The FDA has approved the use of Gozellix, a ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...

The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...